Diabetes Osteoporosis
Diabetes Osteoporosis - Related Videos
02:08
Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis
0 Views •
Cited by 2 •
2024
The placement of implants in a rat model is an essential experimental procedure for clinical research. This study presents a comprehensive surgical protocol for implanting titanium implants into the tibia of rat models with diabetes and osteoporosis.
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
0 Views •
Cited by 98 •
2007
Our protocol was developed to cleanly and easily deliver islets or cells under the kidney capsule of mice. Cells are concentrated into pellets in the final tubing used for transplanting the cells under the kidney capsule. The ease of this technique reduces stress to the cells and the mouse.
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
0 Views •
Cited by 2 •
2007
08:53
Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
0 Views •
Cited by 10 •
2017
Small laboratory fish have become popular models for bone research on the mechanisms underlying human bone disorders and for the screening of bone-modulating drugs. In this report, we describe a protocol to assess the effect of alendronate on bone cells in medaka larvae with osteoporotic lesions.
16:59
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
0 Views •
Cited by 5 •
2012
We describe hepatic neo-islet formation in STZ (streptozotocin)-induced diabetic mice by gene transfer of Neurogenin3 (Ngn3) and Betacellulin (Btc) using helper-dependent adenoviral vector (HDAd) and the reversal of hyperglycemia. Our method takes advantages of helper-dependent adenoviral vectors with their highly efficient in vivo transduction and the long lasting gene expression.
FAQs
Chronic hyperglycemia promotes the accumulation of advanced glycation end products in bone collagen. These chemical changes can impair the material quality of the tissue, so skeletal weakness may reflect altered bone structure as well as changes in mineral content. This mechanism helps explain why fracture risk cannot always be inferred from bone mineral density alone.
Bone strength depends on continuous remodeling, in which old tissue is replaced with new tissue. Diabetes can disrupt this balance and reduce osteoblast function, limiting the formation of healthy bone. Insulin deficiency and diabetes-related inflammation may add further stress to skeletal tissue, producing weakness through several interacting biological pathways rather than one isolated defect.
Bone mineral density measures the amount of mineral in bone, but it does not fully represent bone quality. In diabetes, collagen changes and disrupted remodeling may weaken the tissue without causing a clear reduction in density. Consequently, clinicians should interpret density findings alongside the patient’s diabetes-related skeletal risk and broader fracture-risk assessment.
Assessment should extend beyond a single bone-density result. Diabetes care should include attention to skeletal health, evaluation of fracture risk, and recognition that diabetes may affect both mineral density and bone quality. This broader approach is relevant when identifying patients who may need closer monitoring or preventive management, particularly when measured density does not appear markedly reduced.
Glycemic management is one component of a comprehensive strategy for protecting skeletal health in diabetes. Persistent hyperglycemia contributes to advanced glycation end product accumulation and may interfere with bone remodeling and osteoblast function. Addressing glucose control alongside fracture-risk assessment and prevention strategies connects metabolic care with evaluation of the patient’s long-term skeletal outcomes.
The relationship between diabetes and skeletal fragility is clinically relevant across both type 1 and type 2 diabetes. Although the underlying diabetes context may differ between patients, the need to consider bone strength, bone quality, fracture risk, and glycemic management applies to both groups. Integrating these concerns into routine diabetes care supports a more complete medical assessment.